within last two months. There was no history of jaundice, haemoptysis, chest pain, haematemesis, melaena, haematuria, bone pain, evening rise of temperature or contact with TB patient. Her bowel-bladder habit was normal. On physical examination she was ill looking with below average body built, severely malnourished, moderately anaemic, non icteric, all of her vital parameters were within normal limits. There was a mildly tender lump in left hypochondriac and partly in left lumber region measuring about 10 x 8cm in diameter, globular shape, smooth surface, ill defined margin, firm in consistency, free from anterior abdominal wall, moves side to side but restricted above downward and also not moves with respiration, less prominent in knee-elbow position with no rise of local temperature. There was no organomegaly. All other systemic examination revealed no abnormalities. After proper counselling and preparation laparotomy was done with a view that it is a pancreatic pseudocyst. Peroperative findings was a retroperitoneal mass on left hypochondriac and partly left lumber region with well defined margin and adherent to surrounding structures.There was no lesion in the liver and peritoneal cavity was free from any seedling. The mass was separated from surrounding structures including hilum of the spleen and found arising from tail of pancreas. Lump was adherent to few engorged segmental splenic vessels which were separated later, one was ligated. Lump was removed with part of pancreatic tail without disturbing the duct. Pancreatic tail was sutured by prolene. Proper hemostasis was maintained. Abdomen was closed in layers after keeping 2 drains, 1 in left subhepatic and another in pelvis.
Resected specimen was sent for histopathology. Sections reveal a solid pseudopapillarytumour of pancreas. It is made of uniform polygonal cells arranged around small thin walled blood vessels. Focal hemorrhage, hyalinized areas and a thin fibrous capsule are seen. No malignancy is seen. Post-operative period was uneventful. Oncological consultation was sought and patient was discharged with a proper follow up schedule. SPN can occur in every part of the pancreas but they are slightly more common in the tail 6 . Grossly, it appears as a large and encapsulated mass, generally well-demarcated from the remaining pancreas. In fact, invasion of the adjacent organs, such as the spleen or the duodenal wall, is rare. Depending on the tumor position (head, body or tail of the pancreas), the differential diagnosis includes adrenal mass, pancreatic endocrine tumor, liver cyst or tumor, or a pseudocyst 7 .
Abdominal ultrasound and CT show a well encapsulated, complex mass with both solid and cystic components and 10, 11 In approximately 85% of the patients, SPN is limited to the pancreas, while about 10% to 15% of tumors have already metastasized at the time of presentation 12 . The most common sites for metastasis are the liver, regional lymph nodes, mesentery, omentum and peritoneum.
Once the diagnosis of SPN is made, surgery is the first choice of treatment. SPN is usually surrounded by a pseudocapsule and exhibits benign or low-grade malignancy. Conservative resection with preservation of as much pancreatic tissue as possible is the treatment of choice. According to the location of the tumor, distal pancreatectomy with or without splenectomy, pylorous preserving pancreatoduodenectomy, Whipple operation or enucleation can be performed. Many studies have demonstrated that less aggressive surgical procedures could be preferred for the treatment of SPN 13 Adjuvant therapy is used only in a small number of patients because of the high resectability of SPN. The role of chemotherapy or chemoradiotherapy in the treatment of SPN is also unclear. In some studies, adjuvant chemotherapy and radiotherapy are reported in some unresectable cases with good results 16. Neoadjuvant chemotherapy or chemoradiotherapy is also reported to have been successful in a few cases 17, 18, 19, 20 Conclusions SPN is a rare neoplasm that primarily affects young women. The prognosis is favorable even in the presence of distant metastasis. Although surgical resection is generally curative, a close follow-up is advised in order to diagnose a local recurrence or distant metastasis and choose the proper therapeutic option for the patient.
